Ultralife CEO buys 2,000 ULBI shares at $6.47

Ultralife Corp President and CEO Michael Edward Manna reported an open-market purchase of Ultralife Common Stock.

Rhea-AI Filing Summary

Ultralife Corp President and CEO Michael Edward Manna reported an open-market purchase of Ultralife Common Stock. He bought 2,000 shares at a weighted average price of $6.4693 per share, with individual trade prices ranging from $6.4600 to $6.4700. Following this transaction, his direct holdings increased to 28,674 shares of Ultralife common stock.

Insider Trade Summary

Net Buyer: 2,000 shares

Net Buy 1 txn

Insider Manna Michael Edward

Role President and CEO

Bought 2,000 shs ($13K)

Type	Security	Shares	Price	Value
Purchase	Ultralife Common Stock; $.10 par value	2,000	$6.4693	$13K

Holdings After Transaction: Ultralife Common Stock; $.10 par value — 28,674 shares (Direct)

Footnotes (1)

1. F1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.4600 to $6.4700. The reporting person undertakes to provide upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to the transaction reported on this Form 4.

Key Figures

Shares purchased: 2,000 shares Weighted average purchase price: $6.4693 per share Post-transaction holdings: 28,674 shares +1 more

4 metrics

Shares purchased 2,000 shares Open-market purchase of Ultralife common stock

Weighted average purchase price $6.4693 per share Price for 2,000-share open-market buy

Post-transaction holdings 28,674 shares Direct Ultralife common stock owned after transaction

Price range of trades $6.4600–$6.4700 per share Range for multiple trades in the reported purchase

Key Terms

open-market purchase, weighted average price, Form 4, Ultralife Common Stock; $.10 par value

4 terms

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4 regulatory

"with respect to the transaction reported on this Form 4."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Ultralife Common Stock; $.10 par value financial

"security_title: "Ultralife Common Stock; $.10 par value""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ULBI President and CEO Michael Manna report?

Michael Edward Manna reported an open-market purchase of Ultralife common stock. He acquired 2,000 shares in this transaction, increasing his direct ownership to 28,674 shares, according to the Form 4 insider filing.

At what price did ULBI’s CEO buy Ultralife common stock in this Form 4?

The CEO’s purchase had a weighted average price of $6.4693 per share. The footnote explains the shares were bought in multiple trades at prices ranging from $6.4600 to $6.4700 during the reported transaction.

How many Ultralife (ULBI) shares does Michael Manna own after this transaction?

After the reported open-market purchase, Michael Edward Manna directly owns 28,674 shares of Ultralife common stock. This figure includes the newly purchased 2,000 shares disclosed in the Form 4 insider transaction.

Was the ULBI CEO’s Form 4 transaction a buy or a sell?

The Form 4 shows a buy transaction. Michael Edward Manna executed an open-market purchase of 2,000 Ultralife common shares, classified under transaction code “P” for purchase in open market or private transactions.

Did ULBI’s CEO use a single trade or multiple trades for this stock purchase?

The CEO’s Ultralife share purchase was completed in multiple transactions. A footnote states the price is a weighted average, with individual trades executed between $6.4600 and $6.4700 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Manna Michael Edward

(Last) (First) (Middle)

2000 TECHNOLOGY PARKWAY

(Street)

NEWARK NEW YORK 14513

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ULTRALIFE CORP [ ULBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ultralife Common Stock; $.10 par value	05/18/2026		P		2,000	A	$6.4693(1)	28,674	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.4600 to $6.4700. The reporting person undertakes to provide upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to the transaction reported on this Form 4.

	/s/ Michael E. Manna	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)